← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Microbiotix, Inc.
$3,957,502
Total funding
5
Grants
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$3,957,502 · 5
By mechanism
—$3,957,502 · 5
Investigators at Microbiotix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
NON-STOP RIBOSOME RESCUE INHIBITORS TO TREAT MDR BACTERIAL RESPIRATORY AND SKIN INFECTIONS$1,558,010
· FY2019 · Defense Health Agency
NOVEL THIAZEPINONE PLASMODIAL SURFACE ANION CHANNEL INHIBITORS AS ANTIMALARIAL DRUGS$1,155,860
· FY2016 · Department of the Army
OXADIAZOLE INHIBITORS OF BACTERIAL NONSTOP RIBOSOME RESCUE FOR TREATING TICK-BORNE DISEASES LYME AND TULAREMIA IN MILITARY PERSONNEL, VETERANS AND CIVILIANS$1,023,646
· FY2025 · Defense Health Agency
DEVELOPMENT OF SMALL-MOLECULE INHIBITORS OF FILOVIRUS INFECTION TARGETING NPC1$199,987
· FY2013 · Department of Defense
ANTIBIOTIC POTENTIATORS TARGETING SOS INDUCTION$19,999
· FY2011 · Department of Defense